Noumi Limited (ASX:NOU)
Australia · Delayed Price · Currency is AUD | Market Cap | 27.71M -31.0% |
| Revenue (ttm) | 629.25M +6.2% |
| Net Income | -92.14M |
| EPS | -0.33 |
| Shares Out | 277.11M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 298,048 |
| Average Volume | 77,386 |
| Open | 0.1020 |
| Previous Close | 0.1000 |
| Day's Range | 0.1000 - 0.1050 |
| 52-Week Range | 0.1000 - 0.2000 |
| Beta | 0.29 |
| RSI | 32.18 |
| Earnings Date | May 25, 2026 |
About Noumi
Noumi Limited develops, sources, manufactures, markets, sells, and distributes plant-based and dairy beverages and dairy and nutritional products in Australia, New Zealand, China, Southeast Asia, South Africa, and the Middle East. It operates through Dairy & Nutritionals and Plant-based Milks segments. The company offers full cream, skim, low fat, lactose-free, flavoured, and fortified/specialty milk; cream; protein drinks; dietary enhancements; and nutritional powders. It also provides long-life plant-based milk products, such as soy, almond, ... [Read more]
Financial Performance
In fiscal year 2025, Noumi's revenue was 595.84 million, an increase of 1.03% compared to the previous year's 589.79 million. Losses were -150.00 million, 52.6% more than in 2024.
Financial StatementsNews
Noumi Earnings Call Transcript: H1 2026
Record revenue and EBITDA growth driven by strong Plant-based Milks and Dairy & Nutritionals performance, with significant investments in marketing and innovation expected to fuel future gains. High leverage and commodity price volatility remain key risks as the company plans for 2027 note maturity.
Noumi Earnings Call Transcript: H2 2025
Adjusted operating EBITDA rose 13% to AUD 57.4 million, with strong plant-based and dairy segment growth. Statutory net loss was driven by non-cash items, while legacy issues are resolved and focus shifts to growth and capital planning for 2027 note maturity.
Noumi Earnings Call Transcript: H1 2025
Record results in plant-based milk and improved dairy nutritionals earnings drove a 19% rise in adjusted EBITDA, despite a statutory net loss from significant one-off charges. Strong cash flow and working capital management support continued investment in brand growth and operational efficiency.
Noumi Earnings Call Transcript: H2 2024
Record results in plant-based milks and improved dairy earnings were achieved despite global commodity headwinds. Adjusted EBITDA rose 22% year-over-year, but statutory net loss was impacted by non-cash items. Strategic focus remains on growth, efficiency, and international expansion.